Close Menu

product launch

Fresh off a name change, the company last week introduced a monitoring platform for new SARS-CoV-2 variants that alerts diagnostic test makers to potential problems.

The University of Washington spinout, formerly called Split Biosciences, has received orders for its new whole-transcriptome kit from 50 early-access partners.

Vizgen, Rebus Biosystems, and Veranome Biosystems described their FISH-based platforms for spatial gene expression analysis for the first time.

The assay is being positioned as an alternative to next-generation sequencing-based approaches, which its creators view as ponderous and pricey.

The Seattle-based firm saw collaboration revenues fall 83 percent from Q4 2019 and 73 percent from full-year 2019.


The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.

According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.

CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.

In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.